Toggle navigation
Home
Search
Services
Blog
Contact
About
Insoluble Antineoplastics Paricles for IV Injection
Violante, Michael R.
Sts Biopolymers, Inc., Henrietta, NY, United States
Search 16 grants from Michael Violante
Search grants from Sts Biopolymers, Inc.
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Ohio State University
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Natural audiovisual speech encoding in the early stages of the human cortical hierarchy
Conformational Control of Heterochromatin Formation by the HP-1 Protein from Fission Yeast
Ryanodine receptor in cardiac hypertrophy and heart failure
Database system for patient-based neuroscience research
Development of Spatial Coding
Recently added grants:
Molecular Mechanisms underlying tRNA-fragment regulation of cancer
Exploiting Metabolic Changes in HCC for Cancer Therapy
Multi-site adaptive trial of a technology-based, EHR-integrated physical activity intervention in breast and endometrial cancer survivors
Core A: Lipidomics
Winship National Clinical Trials Network Lead Academic Participating Site
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Small Business Innovation Research Grants (SBIR) - Phase II (R44)
Project #
2R44CA036615-02A1
Application #
3506361
Study Section
Experimental Therapeutics Subcommittee 2 (ET)
Project Start
1986-09-30
Project End
1988-09-29
Budget Start
1986-09-30
Budget End
1987-09-29
Support Year
2
Fiscal Year
1986
Total Cost
Indirect Cost
Institution
Name
Sts Biopolymers, Inc.
Department
Type
DUNS #
City
Henrietta
State
NY
Country
United States
Zip Code
14467
Related projects
NIH 1987
R44 CA
Insoluble Antineoplastics Paricles for IV Injection
Violante, Michael R. / Sts Biopolymers, Inc.
NIH 1986
R44 CA
Insoluble Antineoplastics Paricles for IV Injection
Violante, Michael R. / Sts Biopolymers, Inc.
Comments
Be the first to comment on Michael Violante's grant